Vitality pathway
Libido
Kisspeptin-10 & PT-141
Laboratory verification
Nothing unverified is published
Every compound is prepared to a documented standard. Independent certificates of analysis are published here per batch as they are verified under Nuragen's own governance, we do not reuse another brand's certificates or purity figures.
Certificate of analysis · per batch · on request
Verification-led release
Libido is a research-use-only pairing of two peptides, Kisspeptin-10 and PT-141, grouped under the vitality pathway. It brings together an upstream hormonal-signalling peptide and a centrally-acting peptide as a single subject for laboratory study.
How it is studied
In the research literature, Kisspeptin-10 and PT-141 are examined for the distinct signalling routes they act on rather than for any effect a person might experience. Investigators typically characterise each peptide separately and in combination, looking at how they engage their respective receptors. Work of this kind is carried out in controlled in-vitro and preclinical settings, where the focus is on mechanism and reproducibility.
What the components are and the pathway
Kisspeptin-10 is an upstream hormonal-signalling peptide studied for its role in prompting the release of gonadotropin-releasing hormone within the reproductive signalling axis. PT-141 (bremelanotide) is a centrally-acting peptide researched for its activity at melanocortin receptors in the central nervous system. Pairing an upstream signal with a central-acting compound places both within what NURAGEN groups as the vitality pathway, a framing that describes the biological systems under study, not an outcome.
How it sits in a responsible research programme
Within a structured research programme, a paired compound like this is handled as a defined material with a clear scientific question attached, not as something to be administered. Documentation, controlled storage and consistent handling support the reproducibility that makes findings meaningful. NURAGEN supplies these materials for that context and for no other, keeping the boundary between research use and any human or animal application firmly in place.
Composition
| Component | CAS | Purity |
|---|---|---|
| Kisspeptin-10 | 374675-21-5 | Pending |
| PT-141 | 189691-06-3 | Pending |
| Type | Lyophilised powder |
|---|---|
| Presentation | Lyophilised powder |
| Appearance | White lyophilised powder |
| Storage | Store at 2-8°C, protected from light. |
| Dispatch | Delivered within 72 hours across the UK. |
Handling should follow standard laboratory practice and your own institutional protocols. No dosing, administration or medical guidance is provided.
It is a research-use-only pairing of Kisspeptin-10 and PT-141, intended solely for laboratory investigation. It is not a medicine, supplement or treatment, and it is not for human or veterinary use, consumption or administration of any kind.
As a general handling principle for peptides of this type, storage at 2-8C and protection from light help preserve material integrity for study. Follow the storage guidance supplied with your material and standard laboratory handling practice. We provide handling information as a research reference, not as instructions for any form of use.
No. We do not provide dosing, protocols, administration guidance or medical advice, and none should be inferred from this material. Our information describes what each compound is and what it is studied to do. Clinical or health questions should be directed to a qualified professional.
They act on different points in the signalling picture: Kisspeptin-10 is studied upstream within the hormonal-signalling axis, while PT-141 is studied for its centrally-acting activity at melanocortin receptors. Pairing an upstream and a central-acting peptide lets researchers examine two distinct mechanisms within one defined vitality-pathway material.
In context
Evidence before action
Two peptides that each act on well-described signalling routes are not the same as a finished, validated intervention. Kisspeptin-10 and PT-141 are studied for the pathways they engage, and the value of that work lies in careful, repeatable observation rather than in any assumed result. Reading the primary literature, understanding what a mechanism does and does not tell you, and keeping conclusions proportionate to the data are the habits that let evidence lead. That is what we mean by science, made accountable.
Related pathways
Explore alongside
Vitality
Melanotan 2
Single-component Melanotan II reagent; melanocortin-receptor agonist studied in pigmentation research.
£150
Longevity
Regenesis
Proprietary multi-component longevity blend studied for research use only.
£270
Metabolic
Prime Cut
Multi-component proprietary blend studied in metabolic and growth-signalling research. Research use only.
£250
Recovery
Growth Signal
Paired CJC-1295 and Ipamorelin peptides studied within the recovery pathway.
£160